PMT-13

CCC1=NC(C)=CC(=O)N1CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2

InChIKey=NRFACSVINOXODO-UHFFFAOYSA-N

InChI=1S/C19H21N3O4S/c1-3-16-20-12(2)10-17(23)22(16)8-9-26-14-6-4-13(5-7-14)11-15-18(24)21-19(25)27-15/h4-7,10,15H,3,8-9,11H2,1-2H3,(H,21,24,25)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

PubMed

Title	Date	PubMed
Correlation between activation of PPARγ and resistin downregulation in a mouse adipocyte cell line by a series of thiazolidinediones.	2013-08	23563205

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:55:06 GMT 2025` Edited by `admin` on `Mon Mar 31 22:55:06 GMT 2025`
Record UNII	3MPW0V3XEJ
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

2,4-THIAZOLIDINEDIONE, 5-((4-(2-(2-ETHYL-4-METHYL-6-OXO-1(6H)-PYRIMIDINYL)ETHOXY)PHENYL)METHYL)-

Preferred Name

English

PMT-13

Common Name

English

Code System Code Type Description

FDA UNII

3MPW0V3XEJ

Created by admin on Mon Mar 31 22:55:06 GMT 2025 , Edited by admin on Mon Mar 31 22:55:06 GMT 2025

PRIMARY

PUBCHEM

10068800

Created by admin on Mon Mar 31 22:55:06 GMT 2025 , Edited by admin on Mon Mar 31 22:55:06 GMT 2025

PRIMARY

CAS

199113-95-6

Created by admin on Mon Mar 31 22:55:06 GMT 2025 , Edited by admin on Mon Mar 31 22:55:06 GMT 2025

PRIMARY

Related Record Type Details


					3MPW0V3XEJ

PMT-13

ACTIVE MOIETY